Nektar Therapeutics (NKTR) vs STAAR Surgical Company (STAA)
A side-by-side comparison of Nektar Therapeutics and STAAR Surgical Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NKTR
Nektar Therapeutics
$39.91HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
STAA
STAAR Surgical Company
$22.15HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — NKTR vs STAA
growth of $100 · dividends reinvested · last 10yNKTR -82.3% (-15.9%/yr)STAA +145.3% (+9.4%/yr)STAA compounded faster over this window
Log scale — wide-divergence pair
NKTR STAA
NKTR vs STAA: by the numbers
- •NKTR is the larger company ($1.14B vs $1.10B market cap).
- •STAA is profitable (1.13% net margin) while NKTR runs a net loss (-287.84%).
- •STAA grew revenue faster over the past five years (10.49% vs -12.34% CAGR).
Metrics side by side
Valuation
| Metric | NKTR | STAA |
|---|---|---|
| P/E ratio | N/A | 276.87 |
| Forward P/E | N/A | 76.31 |
| P/S ratio | 20.97 | 3.25 |
| P/B ratio | 1.27 | 3.02 |
| EV / EBITDA | N/A | 22.47 |
Profitability
| Metric | NKTR | STAA |
|---|---|---|
| Gross margin | 99.36% | 76.23% |
| Operating margin | -240.38% | -19.19% |
| Net margin | -287.84% | 1.13% |
| ROE | -17.40% | 1.05% |
| ROIC | -12.53% | 4.80% |
Growth (annualized)
| Metric | NKTR | STAA |
|---|---|---|
| Revenue CAGR (5Y) | -12.34% | 10.49% |
| Total return CAGR (5Y) | -30.33% | -28.41% |
Frequently asked
- Which has grown faster, NKTR or STAA?
- Over the past five years, STAA grew revenue faster — NKTR at a -12.34% CAGR versus STAA at 10.49%.
- Is NKTR or STAA more profitable?
- STAA runs the higher net margin — NKTR at -287.84% versus STAA at 1.13%.
- How have NKTR and STAA total returns compared?
- Over the past 10 years, NKTR delivered -16.49% and STAA delivered 9.25% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.